Encyclopedia of Psychopharmacology

2015 Edition
| Editors: Ian P. Stolerman, Lawrence H. Price

Proteomics

  • Per E. Andrén
  • Peter Verhaert
  • Per Svenningsson
Reference work entry
DOI: https://doi.org/10.1007/978-3-642-36172-2_308

Synonyms

Studies on proteins expressed by the genetic material of an organism

Definition

The proteome is the genome complement of proteins, and proteomics is the study of proteomes in a cell at any given time. Neuroproteomics defines the entire protein complement of the nervous system. It represents a higher complexity than the transcriptome, and it displays a higher degree of dynamics due to posttranslational modifications (PTMs). Two main approaches of this field are profiling and functional proteomics. Profiling proteomics includes the description of the whole proteome of a cell, tissue, organ, or organism and comprises organelle mapping and differential measurement of expression levels between cells or conditions. Functional proteomics aims to characterize protein activity, by determining protein interactions and the presence of PTMs.

Current Concepts and State of Knowledge

The analysis of proteomes is significantly more challenging than that of genomes. Measuring gene expression...

This is a preview of subscription content, log in to check access.

References

  1. Aebersold R, Mann M (2003) Mass spectrometry-based proteomics. Nature 422:198–207PubMedGoogle Scholar
  2. Bayes A, Grant SG (2009) Neuroproteomics: understanding the molecular organization and complexity of the brain. Nat Rev Neurosci 10:635–646PubMedGoogle Scholar
  3. Choudhary J, Grant SG (2004) Proteomics in postgenomic neuroscience: the end of the beginning. Nat Neurosci 7:440–445PubMedGoogle Scholar
  4. Cornett DS, Reyzer ML, Chaurand P, Caprioli RM (2007) MALDI imaging mass spectrometry: molecular snapshots of biochemical systems. Nat Methods 4:828–833PubMedGoogle Scholar
  5. Nilsson A, Falth M, Zhang X, Kultima K, Skold K, Svenningsson P, Andren PE (2009) Striatal alterations of secretogranin-1, somatostatin, prodynorphin, and cholecystokinin peptides in an experimental mouse model of Parkinson disease. Mol Cell Proteomics 8:1094–1104PubMedCentralPubMedGoogle Scholar
  6. Phizicky E, Bastiaens PI, Zhu H, Snyder M, Fields S (2003) Protein analysis on a proteomic scale. Nature 422:208–215PubMedGoogle Scholar
  7. Soloview M, Shaw C, Andrén P (2008) Peptidomics: methods and applications. Wiley, HobokenGoogle Scholar
  8. Stoeckli M, Chaurand P, Hallahan DE, Caprioli RM (2001) Imaging mass spectrometry: a new technology for the analysis of protein expression in mammalian tissues. Nat Methods 7:493–496Google Scholar
  9. Svensson M, Skold K, Nilsson A, Falth M, Nydahl K, Svenningsson P, Andren PE (2007) Neuropeptidomics: MS applied to the discovery of novel peptides from the brain. Anal Chem 79(15–6):18–21Google Scholar
  10. Tyers M, Mann M (2003) From genomics to proteomics. Nature 422:193–197PubMedGoogle Scholar
  11. Westermeier R, Naven T, Höpker HR (2008) Proteomics in practice: a guide to successful experimental design, 2nd edn. Wiley-VCH, WeinheimGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2015

Authors and Affiliations

  • Per E. Andrén
    • 1
  • Peter Verhaert
    • 2
  • Per Svenningsson
    • 3
  1. 1.Biomolecular Imaging and Proteomics, National Laboratory for Mass Spectrometry Imaging, Department of Pharmaceutical BiosciencesUppsala UniversityUppsalaSweden
  2. 2.Department of BiotechnologyNetherlands Proteomics Centre, Delft University of TechnologyDelftNetherlands
  3. 3.Department of Physiology and PharmacologyKarolinska Institute, Hasselt UniversityStockholmSweden